Print this page
 Email this page

 Connect with UMMC on:
 Twitter
 Facebook
 YouTube
iPhone

 Share this page:

Bookmark and Share

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

 

Ask the Expert

Growth and Nutrition Experts’s Bio Image

Get answers to your child's growth, nutrition, and feeding behavior questions.

Growth and Nutrition Experts’s Bio | Q&A Archive

Note: This is for informational purposes only. Doctors cannot provide a diagnosis or individual treatment advice via e-mail. Please consult your physician about your specific health care concerns.

Video details

[ Flash player icon ] Please install flash player to see this video.

Related Content


 

Newborn jaundice - Overview

Alternative Names

Jaundice of the newborn; Neonatal hyperbilirubinemia

Definition of Newborn jaundice:

Newborn jaundice is a condition marked by high levels of bilirubin in the blood. The increased bilirubin cause the infant's skin and whites of the eyes (sclera) to look yellow.

Causes, incidence, and risk factors:

Bilirubin is a yellow pigment that's created in the body during the normal recycling of old red blood cells. The liver processes bilirubin in the blood so that it can be removed from the body in the stool.

Before birth, the placenta -- the organ that nourishes the developing baby -- removes the bilirubin from the infant so that it can be processed by the mother's liver. Immediately after birth, the baby's own liver begins to take over the job, but this can take time. Therefore, bilirubin levels in an infant are normally a little higher after birth.

High levels of bilirubin in the body can cause the skin to look yellow. This is called jaundice. Jaundice is present to some degree in most newborns. Such "physiological jaundice" usually appears between day 2 and 3, peaks between days 2 and 4, and clears by 2 weeks. Physiological jaundice usually causes no problems.

Breast milk jaundice is another common, usually non-harmful form of newborn jaundice. Breast milk may contain a substance that increases reuse of bilirubin in the intestines. Such jaundice appears in some healthy, breastfed babies after day 7 of life, and usually peaks during weeks 2 and 3. It may last at low levels for a month or more.

Breastfeeding jaundice is a type of exaggerated physiological jaundice seen in breastfed babies in the first week, especially in those that are not nursing often enough. It is different than breast milk jaundice in that it occurs later and is caused by the milk itself.

Sometimes jaundice can be a sign of a serious underlying problem. Higher levels of bilirubin can be due to:

  • An event or condition that increases the number of red blood cells that needs to be processed
  • Anything that interferes with the bodyâ ' s ability to process and remove bilirubin

The following increase the number of red blood cells that need to be processed:

  • Abnormal blood cell shapes
  • Blood type incompatibilities
  • Cephalohematoma or other birth injury
  • Glucose-6-phosphate dehydrogenase deficiency
  • High levels of red blood cells (polycythemia)
    • More common in small for gestational age babies
    • More common in some twins
  • Infection
  • Prematurity
  • Pyruvate kinase deficiency
  • Transfusions

The following interfere with the body's ability to process and remove bilirubin:

In otherwise healthy babies born at 35 weeks gestation or greater, those most likely to eventually develop signs of newborn jaundice are those who have:

  • A brother or sister who needed phototherapy for jaundice
  • A high bilirubin level for their age, even if they are not yet jaundiced
  • Been exclusively breastfeed, especially if weight is excessive
  • Blood group incompatibility or other known red blood cell disease
  • Cephalohematoma or significant bruising
  • East Asian ancestry
  • Jaundice in the first 24 hours of life
  • Reviewed last on: 12/1/2008
  • Neil K. Kaneshiro, MD, MHA, Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc. Previously reviewed by Alan Greene, MD, FAAP, Department of Pediatrics, Stanford University School of Medicine, Lucile Packard Children's Hospital; Chief of Future Health, A.D.A.M., Inc., September 2007.

References

American Academy of Pediatrics (AAP). Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004 Jul;114(1):297-316.

Mercier CE, Barry SE, Paul K, et al. Improving Newborn Preventive Services at the Birth Hospitalization: A Collaborative, Hospital-Based Quality-Improvement Project. Pediatrics. 2007 Sep;120(3):481-488.

Moerschel SK, Cianciaruso LB, Tracy LR. A practical approach to neonatal jaundice. American Family Physician. 2008 May;77(9).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com